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Background: The substitution principle has been included in the EU pesticides legislation as a new element.
Comparative assessments will have to be conducted for all uses of plant protection products (PPPs) that contain
active substances with certain hazardous properties, the so-called candidates for substitution (CFS). This study
investigated the resulting workload in terms of the number of cases for comparative assessments that regulatory
authorities may have to face. The analysis was carried out for Germany as an example.
Main text: In Germany, the requirement for comparative assessments may affect up to 25% of all PPPs and around
50% of all uses of PPPs. In absolute terms, these are around 350 candidate products with 1,850 different uses.
Alternative products without CFS may be available for around 40% of these uses. On average, a candidate product
is authorised for around 18 different uses. For 11 of these uses, no alternatives are authorised. For the remaining
seven uses, slightly more than seven alternatives are available on average. Multiplication of these factors gives an
indicative figure of around 18,500 possible pairwise comparisons of candidate products with alternative products
for every common use.
Conclusions: The high number of expectable cases poses a formidable challenge for the efficient conduct of the
new task of comparative assessments by competent Member States authorities. To this end, new data handling
systems, assessment procedures, and decision rules need to be established.
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The substitution principle in the EU pesticides legislation
The substitution principle is a new element of the legisla-
tion on plant protection products (PPPs) in the European
Union (EU). It was introduced with the new Regulation
(EC) No 1107/2009 [1], in the following shortly denoted
as the PPP Regulation. This replaced the old Directive 91/
414/EEC on PPPs [2] in June 2011. In parallel, the substi-
tution principle was also included in the new Regulation
(EU) No 528/2012 on biocidal products [3], which came
into force in September 2013. PPPs and biocidal products* Correspondence: rolf.altenburger@ufz.de
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in any medium, provided the original work is pare collectively denoted as ‘pesticides’ under EU law, as
has been defined in Article 3 of Directive 2009/128/EC on
the sustainable use of pesticides in the European Commu-
nity (EC) [4]. As a common rule, pesticides shall not be
placed on the market or used unless they have been
authorised in accordance with the applicable regulations.
In general, ‘substitution’ of pesticides means that an au-
thorisation is refused or withdrawn in favour of an alter-
native product or a non-chemical control or prevention
method which presents a ‘significantly lower risk’, accord-
ing to Annex IV of the PPP Regulation (EC) No 1107/
2009 and Article 23 of the biocidal products Regulation
(EU) No 528/2012, respectively. In detail, the conditions,
rules, and criteria for applying the substitution principleopen access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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focus on substitution under the Regulation for PPPs.
The inclusion of the substitution aspect in the EU
pesticides legislation is an outcome of a broader and
long-lasting discussion about the guiding principles of
chemicals regulation under EU law. As a generic policy
principle, substitution means the replacement of hazard-
ous chemical substances and products by less hazardous
alternatives [5]. Whether this idea should be established
as a legal demand for actors in the field has been subject
to heated debates. Opponents, such as the German chem-
ical industries for instance, argued that substitution was
superfluous if safe use of a hazardous chemical could be
ensured by appropriate risk management measures [6]. In
2001, during the preparation of the REACH legislation,
the Commission of the European Communities (COM)
considered the substitution of hazardous chemicals as one
of the ‘key elements’ of the proposed ‘Strategy for a future
Chemicals Policy’ [7]. Five years later, in the final REACH
legislation [8], legal requirements for feasibility analyses
for substitution were, however, confined to substances of
very high concern (SVHC) that are subject to authori-
sation (Article 55 of Regulation (EC) No 1907/2006). In all
three pieces of legislation, where substitution has now
been included as an element of authorisation procedures
(REACH, biocidal products and PPPs), hazardous proper-
ties of chemicals serve only as a trigger for considerations
for substitution, but are considered insufficient for deci-
sion making. Instead, comparative risk assessments of
products have to be conducted as the basis for substitu-
tion decisions, which is novel and challenging.
Conventional risk assessments for individual PPPs, as
they have been established under the old Directive
91/414/EEC, aim to ensure that regulatory acceptable
exposure levels are not exceeded, but they do not
provide incentives for reducing risks any further. This
is changed by the complementary instrument of compa-
rative risk assessment which supports a process of con-
tinuous improvement by identifying those PPPs that allow
to achieve a desired purpose with minimal risks at a given
point in time. This is particularly favourable for environ-
mental risks, where the authorisation requirements still
allow to tolerate temporary adverse effects as acceptable.
Moreover, acceptable exposure levels for many pesticides
on the market are only achievable by applying risk mitiga-
tion measures, such as protective equipment for workers
or buffer zones between sprayed agricultural land and sur-
face waters. Such measures may fail accidentally or may
be disregarded negligently. Substitution of such products
by alternatives that require less risk mitigation measures is
therefore desirable and shall be supported by the new
instrument of comparative assessments.
While the intended improvements are clear, the detailed
procedures and methodologies for applying the substitutionprinciple are not. Only in the Nordic countries, parti-
cularly in Sweden, the principle has been included in the
national chemicals legislation since the beginning of the
1990s [9]. Other EU Member States (MS) have no com-
parable legislative tradition. Against this background, there
is high uncertainty about potential impacts of this new
element of EU pesticides legislation and the best way
towards its efficient implementation.
Candidates for substitution
Plant protection products contain one or more active
substances. Under EU law, PPPs are authorised on the
Member States level, while active substances are approved
on the Community level. Approved active substances are
included in a positive list established by the European
Commission. Member States shall not authorise PPPs that
contain active substances other than those on the positive
list. Authorisations are only granted for specified uses,
usually defined by a combination of a protected crop and
a targeted pest.
The revised legislation now requires that certain active
substances shall be approved by the European Commis-
sion only as ‘candidates for substitution’ (CFS) and listed
separately from other approved active substances. Mem-
ber States shall not grant authorisation to PPPs that
contain such CFS, if a comparative assessment reveals
that a significantly safer alternative is available for the
same use.
CFS are active substances that have one or more of
the hazardous properties listed in Table 1. As laid down
in the PPP Regulation, their identification constitutes
one task within the regular assessment of active substances
on Community level. In order to speed up the process for
the already approved active substances, an obligation for
the European Commission (COM) was included in the
PPP Regulation to establish an initial list of CFS until the
end of 2013. However, completion of this task is now ex-
pected to be delayed by a few months [10]. At the time of
writing of this manuscript (March 2014), the official list
was not yet available.
As a support for the preparation of the initial list,
COM commissioned a contract study to the Food Chain
Evaluation Consortium (FCEC). The FCEC delivered their
study report in July 2013 [11]. Subsequently, the re-
port was presented to the competent authorities of
the Member States, and it was made available to all
stakeholders via the Commission's CIRCA platform
[12].Thus, although not formerly published, the report
is in the public domain and was accessible for the pur-
poses of this paper via the German Federal Environment
Agency (UBA).
It was not the task of the FCEC to set up the initial list
of CFS - this is the privilege of COM - but to do the
necessary preparatory work, which was
Table 1 Criteria for the identification of active substances as candidates for substitution (CFS)
Number Legal text (Regulation (EC) No 1107/2009, Annex II, point 4) [1]a
1 Its ADI, ARfD, or AOEL is significantly lower than those of the majority of the approved active substances within groups of
substances/use categories
2 It meets two of the criteria to be considered as a PBT substance
3 There are reasons for concern linked to the nature of the critical effects (such as developmental neurotoxic or
immunotoxic effects) which, in combination with the use/exposure patterns, amount to situations of use that could still
cause concern, for example, high potential of risk to groundwater; even with very restrictive risk management measures
(such as extensive personal protective equipment or very large buffer zones)
4 It contains a significant proportion of non-active isomers
5 It is or is to be classified, in accordance with the provisions of Regulation (EC) No 1272/2008, as carcinogen category 1A or 1B,
if the substance has not been excluded in accordance with the criteria laid down in point 3.6.3b
6 It is or is to be classified, in accordance with the provisions of Regulation (EC) No 1272/2008, as toxic for reproduction category
1A or 1B if the substance has not been excluded in accordance with the criteria laid down in point 3.6.4b
7 If, on the basis of the assessment of Community or internationally agreed test guidelines or other available data and information,
reviewed by the Authority, it is considered to have endocrine disrupting properties that may cause adverse effects in humans if
the substance has not been excluded in accordance with the criteria laid down in point 3.6.5b,c
aThe criteria apply independently, i.e. CFS meet one or more of them. bPoints 3.6.2 to 3.6.5 of Annex II of Regulation (EC) No 1107/2009 [1] define hazard-based
criteria for substances that must not be approved, so-called cut-off criteria. cFor endocrine disrupters, currently the interim criteria laid down under point 3.6.5 of
Annex II of Regulation (EC) No 1107/2009 [1] apply, i.e. substances classified as carcinogenic category 2 and toxic for reproduction category 2.
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from the legally relevant documents, i.e. those
documents on which the original decisions for
approval of active substances have been based,
such as the official Review Reports, EFSA
Conclusions, and Draft Assessment Reports, and
(ii) to explore options for the interpretation and
operationalisation of the criteria for the
identification of CFS (Table 1), where the legal text
and the available data leave room for judgments and
where corresponding rules for data assessments had
not already been fixed in a corresponding
Commission Working Document on ‘Evidence
Needed to Identify POP, PBT and vPvB Properties
of Pesticides’ [13].
As a consequence, the FCEC report did not directly
provide a list of CFS, but it included separate lists of
active substances that were considered to fulfil individual
CFS criteria or sub-criteria, for example persistence in
soil, in sediments, and in water. Where applicable,
the report provided various versions of these lists,
each representing the outcome of a different inter-
pretation of a legal criterion, such as different measures
and trigger values for a ‘significantly lower ADI’. In each
of these cases the report provided arguments for the
option that the authors considered to be the most ap-
propriate one.
Thus, by combining the information from these in-
dividual lists, it is possible to obtain a list of potential
CFS that have a high chance for becoming actually
included in the initial list of CFS that COM is going
to establish. This opportunity was used for the purpose of
this study.Comparative assessments
In the future, EU Member States shall perform a compara-
tive assessment whenever they evaluate any application
for authorisation of a PPP that contains a CFS, in the fol-
lowing shortly denoted as candidate product. A compara-
tive assessment may be initiated by an application for the
authorisation of a new candidate product, for the renewal
of an existing authorisation, or for the amendment of an
authorisation for new uses of a candidate product. Com-
parative assessments must be performed for each use
of a candidate product. A candidate product shall not
be authorised for a use for which an alternative chemical
product or a non-chemical control method is available, if
the following requirements are fulfilled (Article 50 in con-
junction with Annex IV of the PPP Regulation):
(i) Experience from practical use of the alternative is
available.
(ii) The alternative has a comparable efficacy against
target pests.
(iii) The alternative can be used without significant
economic or practical disadvantages, including
impacts on the so-called minor uses.
(iv) The substitution does not compromise resistance
management and the minimisation of the
occurrence of resistance.
(v) The alternative product or method is ‘significantly
safer for human or animal health or the
environment’.
Thus, the comparative assessment can be divided into
two major parts: a comparative agronomic assessment
covering points (i) to (iv) and a comparative safety assess-
ment as required by point (v). This paper focuses on the
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comparisons of chemical PPPs with non-chemical protec-
tion methods (e.g. mechanical methods or bio-pesticides
such as viruses and bacterial strains).
Annex IV to the PPP Regulation clarifies that the
increase in safety that is achieved by a substitution shall
be demonstrated in terms of a ‘significantly lower risk’.
In general, competent authorities shall identify such sig-
nificant differences in risk ‘on a case-by-case basis’. A
significance level is not specified for the comparative hu-
man health risk assessment but for the environmental
risk assessment: ‘if relevant, a factor of at least 10 for the
toxicity/exposure ratio (TER) of different plant pro-
tection products is considered a significant difference
in risk’ [1].
For conducting the agronomic part of the comparative
assessments, guidance has been developed by EPPO, the
European and Mediterranean Plant Protection Organiza-
tion [14]. For the risk assessment part, COM is currently
working on a guidance document, based on a proposal
by Sweden [15]. This guidance aims to support the
Member States, but it will not establish detailed and
legally binding rules. Basically, it will be up to the deci-
sion of the Member States on how they actually conduct
comparative risk assessments.
Regulatory impact
In order to prepare for the new task of conducting
comparative product assessments, competent authorities
need to obtain an overview about the dimension of the
additional workload they may be confronted with. Earlier
assessments of the potential impacts of the new PPP legis-
lation estimated that about 15% to 25% of the approved
active substances could become candidates for substitu-
tion [16,17], but these studies were based on limited and
uncertain databases and they did not further explore the
consequences in terms of numbers of potentially affected
products and uses of products, and in terms of numbers
of pairs or groups of products that could become subject
to a comparative risk assessment. However, with the data
from the recent FCEC report, a solid basis is now available
for such calculations.
Aims and approach
This study aimed to estimate the potential number of
cases for which a comparative assessment will need to be
carried out, in terms of (i) the number of CFS-containing
candidate products, (ii) the number of different uses of
such candidate products, (iii) the number of uses of candi-
date products for which alternative products are available,
and (iv) the possible number of pairwise comparisons of
candidate and alternative products for all common uses.
For the purpose of this study, we assumed that candidate
products are only compared to alternative products thatdo not contain any CFS. In principle, neither the legal text
nor the available draft of the EU Guidance Document
excludes the possibility of a substitution of a candidate prod-
uct by another candidate product, if a significant risk reduc-
tion would result. However, we assumed that this would be
a rare situation and excluded it from further consideration.
The exercise did not cover the whole European Union
but was conducted for the German PPP market as an
example. The calculations were based on the simplistic
assumption of a static market share of candidate products.
This means that authorisations for all uses of all CFS-
containing PPPs that are currently on the market would
become subject to renewal in the future or that they will
be replaced by an equal number of new candidate
products with an equal number of uses. In this way
we assumed to obtain upper limit estimates of the poten-
tial number of cases for comparative assessments that
may accumulate over a period of time equal to the average
duration of authorisations (typically granted for 10 years).
The identification of CFS results from hazardous prop-
erties for humans or for the environment or for both.
For human and environmental risk assessments of PPPs,
different aims, methods, and procedures apply and they
are often performed separately by different institutions.
In Germany, for instance, the Federal Institute for Risk
Assessment (BfR), the Julius Kühn Institute (JKI), and the
Federal Environment Agency (UBA) separately assess risks
for humans, for honey bees, and for the environment,
respectively. Therefore, we were also interested to see
whether the number of cases for comparative risk assess-
ments would be significantly reduced, if comparative
environmental assessments would be conducted only
for those candidate products that contain CFS as identi-
fied by hazardous environmental properties. To this end,
we performed all calculations twice: once for all candidate
products and once only for those products that contain
CFS that have been identified for reasons of environmen-
tal hazards (exclusively or in addition to human health
hazards). The way by which we achieved this discrimin-
ation is explained in the ‘Main text’ section.
The list of potential CFS resulting from the FCEC
report is currently subject to final revisions by the Com-
mission and the Member States. In order to avoid any
false discrimination of substances or products in this
interim situation, this paper is exclusively focused on the
quantitative aspects of the subject, providing numbers of
substances, products, and uses, but no names. As a result
of the ongoing revisions, the forthcoming official CFS list
can be expected to be slightly but not substantially shorter
than assumed in this paper [10]. Consequently, the figures
provided in this paper for the number of candidate prod-
ucts can be expected to represent a slight overestimation
of the findings that will be obtainable by performing the
same analyses on the basis of the final CFS list.
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How many CFS?
Almost 100 active substances are potential candidates for
substitution, which is roughly a quarter of all approved
active substances. This derives from an examination of the
information provided in the FCEC report to the Commis-
sion [11], as detailed in the ‘Methods’ section. The number
refers to the list of approved active substances laid down
in the Annex to Commission Implementing Regulation
(EU) No 540/2011 [18], as amended until 31 January
2013. Where the legal definition of an approved active
substance includes different varieties of a parent com-
pound or where the approval applies to a defined group of
compounds, these were counted as a single entity. Earlier
impact studies expected CFS proportions between 15%
and 25% [16,17]. Our findings show that these prognoses
indicated the dimension of the problem quite accurately.
Potential CFS are spread across all major use categories,
as defined in the EU Pesticides database [19]. Between
10% and 25% of substances used as fungicides, insecti-
cides, plant growth regulators, or multi-purpose pesticides
are potential CFS (Table 2). For acaricides and herbi-
cides, the proportions are higher, with around 40% of
the substances being potentially affected. From the small
group of rodenticides, even 60% are potential CFS.
The so-called PBT properties have an outstanding
importance for the number of substances identified as aTable 2 Proportion of active substances identified as
potential CFS, broken down by use categories













Not assigned 6 0
All 378 26
aAssignment to use categories as given in the EU Pesticides database [19]; AC,
acaricides; FU, fungicides; HB, herbicides; IN, insecticides; PG, plant growth
regulators; RE, repellents; RO, rodenticides; Other, attractants, bactericides,
elicitors, molluscicides, nematicides, and plant activators; Multi, multiple use
categories apply to the same substance, also including uses as dessicant in
addition to one or more of the other listed categories. bReference date: 31
January 2013; counting of approved active substances refers to the legal
definitions listed in Commission Implementing Regulation (EU) 540/2011 [18];
from a chemical perspective, parts of these are groups of substances or
mixtures of substances; in addition to chemicals, the legal substance definition
also includes viruses and bacteria, the so-called bio-pesticides. cPercentages
rounded to integer values; potential CFS are those identified in the FCEC
report [11], as detailed in the text.potential CFS (Table 3). Almost 80% of the potential CFS
fulfil the second CFS criterion (see Table 1), which means
that they meet two of the criteria to be considered as
persistent (P), bioaccumulative (B), and/or toxic (T), as
defined under point 3.7.2 of Annex II to the PPP Regula-
tion. Low ADI, ARfD, or AOEL values; reproductive tox-
icity class 1A or 1B; or endocrine disrupting properties
(criteria 1, 6, and 7 in Table 1) have a lower impact on the
number of potential CFS, i.e. 22%, 9%, and 7% of the can-
didates, respectively. Even less influence on the number of
CFS has criterion 4 (Table 1), i.e. a significant proportion
of non-active isomers: only 2% of the potential CFS meet
this criterion. The remaining two criteria 3 and 5 (‘nature
of critical effects’ and carcinogens class 1A/1B) were not
found to apply to any approved active substances in the
FCEC report. Sixteen percent of all potential CFS were
found to meet two or more of the seven identification cri-
teria. There is no obvious association between applicable
CFS criteria and the use categories of substances (Table 3).
Substances meeting two PBT criteria, for instance, come
from all major use categories, whereupon the proportions
basically reflect the different sizes of the use groups.
The seven legal CFS criteria include both human
health hazards and environmental hazards, but both as-
pects are separable, as explained in the following. CFS
criteria 1, 5, 6, and 7 (low ADI/ARfD/AOEL, carcino-
genicity, reproductive toxicity, and endocrine disrupting
properties that may cause adverse effects in humans as
defined in the legislation) are exclusively based on tests
used for human toxicity assessments. Criterion 3 (nature
of critical effects) could be interpreted to include both
aspects but was not found to be relevant for the initial
list of CFS. Criterion 4 (non-active isomers) clearly
has a relevance for both human and environmental
hazard and risk assessments. Criterion 2 (two PBTcriteria)
theoretically comprises three different situations: P + B,
P + T, and B + T. Practically, however, the combination
P + B has apparently no relevance for the initial CFS
list. Hence, criterion 2 always combines an exposure indi-
cator (P or B) with a toxicity indicator (T). As laid down
under point 3.7.2.3 of Annex II of the PPP Regulation, two
different types of toxicity indicators are applicable: in-
dicators of human toxicity (CMR and STOT RE clas-
sifications) and indicators of aquatic toxicity (long-term
NOEC), in the following denoted as THUMAN and TAQUA,
respectively. As a consequence, it is possible to distinguish
between CFS that meet criterion 2 for reasons of human
health protection (THUMAN in combination with P or B)
or for reasons of environmental protection (TAQUA in
combination with P or B), or both. In summary of these
considerations, CFS identified by environmental hazard cri-
teria are those that meet the T criterion for water organisms
in addition to the P or the B criterion, and those that con-
tain a significant proportion of non-active isomers.
Table 3 Breakdown of the number of potential CFS by use categories and identification criteria
CFS criteriona Use categorye Sum
AC FU HB IN PG RO Multi
1. Low ADI/ARfD/AOEL 0 6 8 2 1 0 5 22
2. Two PBT criteria TAQUA
b 3 20 32 8 2 2 3 70
THUMAN
c 0 8 8 1 0 0 3 20
All 3 23 35 8 2 2 4 77
3. Nature of critical effects 0 0 0 0 0 0 0 0
4. Non-active isomers 0 1 1 0 0 0 0 2
5. Carcinogen 1A/1B 0 0 0 0 0 0 0 0
6. Toxic for reproduction 1A/1B 0 3 5 0 0 1 0 9
7. Endocrine disrupting propertiesd 0 2 4 1 0 0 0 7
All 3 26 45 10 3 3 8 98
aThe numbering refers to the full legal definition of criteria as given in Table 1; corresponding short descriptions are those used in the EU pesticide database [19];
different criteria for identification as a CFS may apply to one and the same substance; therefore figures in lines ‘All’ do not equal sums of values given in the
columns. bTAQUA: substances fulfil the toxicity criterion for water organisms laid down under point 3.7.2.3 of Annex II to Regulation (EC) No 1107/2009 [1], in
addition to the P or the B criterion. cTHUMAN: substances fulfil any of the human toxicity criteria defined under point 3.7.2.3 of Annex II to Regulation (EC) No 1107/
2009 [1] in terms of CMR or STOT RE classifications, in addition to the P or the B criterion. dFor endocrine disrupters, the interim criteria laid down under point
3.6.5 of Annex II of Regulation (EC) No 1107/2009 [1] were applied, i.e. substances classified as carcinogenic category 2 and toxic for reproduction category 2.
eAssignment to use categories as given in the EU Pesticides database [19]; AC, acaricides; FU, fungicides; HB, herbicides; IN, insecticides; PG, plant growth
regulators; RO, rodenticides; Multi, multiple use categories apply, also including uses as dessicant, nematicide, or repellent in addition to one or more of the
categories AC, FU, HB, IN, PG, and RO.
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hazards.
By applying these categorisations, we found that only
19% of the potential CFS are exclusively identified by
human health criteria; 81% meet environmental hazard
criteria, whereby 27% meet both human and environ-
mental hazard criteria and 54% are exclusively identified
for reason of environmental hazards.
How many candidate products?
The analysis of the German register of authorised PPPs
revealed that 25% of the products contain one or more
potential CFS and may hence be considered as potential
candidate products (Table 4). This proportion is almost
identical to the share of CFS in the number of approved
active substances. Interestingly, however, only 67 out of
98 potential CFS were actually found in any PPP on the
German market, i.e. around 30% of the CFS currently have
no relevance for comparative assessments in Germany. In
absolute figures, 351 out of 1,378 authorised PPPs are
potential candidate products. Two hundred thirty-seven
products contain a potential CFS that has been identified
for reason of environmental hazards, which is a share of
17% of all products and 67% of all potential candidate
products. Thus, on the level of products on the German
market, the importance of environmental hazard criteria
for the number of candidates is only slightly lower than
seen on the level of active substances, where the corre-
sponding fraction is 81% of all potential CFS.
The potential candidate PPPs are spread across seven
major use categories, with shares ranging between 2%and 45%. This is essentially the same situation as observed
on the level of CFS. Interestingly, however, the propor-
tions can be quite different for the same use category. In
the small group of rodenticides, for instance, 60% of the
active substances were found to be potential CFS, but no
more than 2% of the rodenticidal products authorised in
Germany actually contain any of these CFS. The opposite
situation does also occur: In the large group of fungicides,
for instance, 25% of the active substances are potential
CFS, but 45% of the products on the German market con-
tain one or more of these CFS. The high proportion of
45% potential candidate products amongst fungicides is
exceptional; for all other use categories, the fractions are
at or below the average of 25%.
How many uses of candidate products?
On average, potential candidate products are authorised
for a broader spectrum of uses than other PPPs. As a con-
sequence, they may necessitate comparative assessments
for a disproportionally high number of uses; they account
for no more than 25% of all products (see above), but they
are authorised for around 50% of all uses. This is the
essential outcome of an analysis detailed in the following.
Authorised uses of PPPs are defined in terms of a
combination of a crop and a pest from which the crop
shall be protected. A small number of other treatment
objects (such as food storage rooms) and treatment aims
(such as plant growth regulation) are subsumed here
also under the terms crop and pest, respectively. Using
the status of May 2013, a total of 1,378 PPPs was authorised
in Germany for a total of 3,606 uses, defined as different
Table 4 Proportion of candidate products containing potential CFS authorised in Germany
Use categorya Total number of authorised PPPsb Proportion of candidate PPPs containing one or more potential CFSc
Containing any
potential CFS (%)
Containing CFS identified by
environmental hazard criteriad (%)
Herbicides 567 25 21
Fungicides 308 45 32
Insecticides 281 25 6
Acaricides 109 12 2
Plant growth regulators 59 14 7
Molluscicides 58 0 0
Rodenticides 41 2 2
Glue, sealing wax 31 0 0
Repellents 29 0 0
Sprout inhibitors 18 0 0
Bactericides 9 11 11
Pheromones 3 0 0
Viricides 1 0 0
Nematicides 1 0 0
Allb 1,378 25 17
As of May 2013. aCategorisation as given in the BVL database on plant protection products [20]; this categorisation of products is largely but not entirely
consistent with the categorisation of active substances used in the EU pesticide database [19] (see preceding tables). bThe given categorisation of products is
non-exclusive, i.e. multiple use categories may apply to a single product; this is the case for around 10% of all PPP; as a consequence, the overall number of 1,378
PPPs is smaller than the sum of values in the column. cPercentages rounded to integer values; potential CFS are those identified in the FCEC report [11], as detailed in
the text. dActive substances that fulfil the toxicity criterion for water organisms laid down under point 3.7.2.3 of Annex II to Regulation (EC) No 1107/2009 in addition to
the P or the B criterion as defined under points 3.7.2.1 and 3.7.2.1 of the same Annex II [1], and active substances that contain a significant proportion of non-active
isomers; human health criteria may apply additionally.
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(Table 5). The fraction of 351 potential candidate products
(25% of all products) was authorised for a total of 1,863
uses (52% of all uses), defined as different combinations
from 209 crops (68% of all crops) and 264 pests (55% of all
pests). The sub-fraction of 237 potential candidate prod-
ucts that contain CFS identified by environmental hazard
criteria (17% of all products) was authorised for a total of
1,501 uses (42% of all uses), defined as different combi-
nations from 186 crops (60% of all crops) and 228 pests
(48% of all pests).
On average, every PPP is authorised for use against
five different pests in seven different crops. For potential
candidate products, the same mean values apply. On the
level of uses, however, the situation is different: while the
mean number of authorised uses is 13 for all PPPs, poten-
tial candidate products have an average of 18 different
authorised uses.
How many alternatives are available?
For 767 different uses of potential candidate products, at
least one CFS-free alternative product is authorised (Table 6).
This is slightly more than 40% of all 1,863 uses of poten-
tial candidate products. For around 9%, even more than
10 different alternative products are authorised. For thesub-fraction of potential candidate products that contain
CFS identified by environmental hazard criteria, the cor-
responding proportions are slightly higher: at least one
alternative is available for 687 of 1,501 uses, i.e. almost
46%. For almost 12%, even more than 10 different alterna-
tive products are authorised.
On average, one or more alternative products are
authorised for around 7 out of 18 different uses of a
potential candidate product. For each of these seven uses,
the mean number of available alternative products is also
around seven. For the sub-fraction of potential candidate
products that contain CFS identified by environmental
hazard criteria, these mean values differ only marginally.
How many cases for comparative assessments?
In principle, every application for authorisation of a
candidate product constitutes a case for comparative
assessments, as required by the PPP Regulation. While the
assessments may be stopped in an early phase, if alterna-
tives are not available for any of the uses of the candidate
product, our analysis revealed that only for 6 out of 351
potential candidate products no alternative products
are authorised for any of their uses. The remaining 345
potential candidate products (around 98%) may trigger
more detailed comparative assessments, at least of the
Table 5 Number of plant protection products, protected crops, controlled pests, and authorised uses in Germany
Parameter All PPPs Candidate PPPs containing one or more potential CFS
Containing any
potential CFS
Containing CFS identified by
environmental hazard criteriaa
Products Total number 1,378 351 237
Cropsb Total number of different crops for which use of
PPPs has been authorised
309 209 186
Number of different crops for which use of an
individual PPP has been authorised
Min 1 1 1
Max 85 85 85
Median 4 4 4
Meane 7 7 7
Pestsc Total number of different pests against which use
of PPPs has been authorised
477 264 228
Number of different pests against which use of
an individual PPP has been authorised
Min 1 1 1
Max 64 39 39
Median 3 4 4
Meane 5 5 5
Usesd Total number of different uses for which PPPs
have been authorised
3,606 1,863 1,501
Number of different uses for which an individual
PPP has been authorised
Min 1 1 1
Max 337 337 337
Median 6 8 9
Meane 13 18 18
As of May 2013. Broken down by potential CFS content of products. aAs defined in the corresponding footnote to Table 4. bIncluding other authorised treatment
objects such as food storage rooms for instance. cIncluding other authorised treatment aims such plant growth regulation for instance. dDefined by a combination
of a crop (or another treatment object) and a pest from which the crop shall be protected (or another treatment aim). eArithmetic mean rounded to integer
values.
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http://www.enveurope.com/content/26/1/11agronomic aspects, and where appropriate also of the
safety aspects. For the sub-fraction of potential candidate
products that contain CFS identified by environmental
hazard criteria, the proportion is basically the same
(Table 7).
In terms of affected uses, more or less detailed compara-
tive assessments may be required for the 767 different
uses of potential candidate products for which at least one
alternative product is currently authorised. However, even
for the same use, not all candidate products will become
subject to authorisation or re-authorisation at the same
time. Whenever an authorisation is requested for a single
candidate product, comparative assessments will have to
be conducted for all its uses. This means that comparative
assessments for the same use may have to be conducted
repeatedly over time. Therefore, as an additional indicator
of the potential workload for competent authorities, the
number of potential candidate products can be multiplied
with the average number of uses for which alternatives are
potentially available. This yields an indicative figure of
roughly 2,500 cases of use-specific assessments of candi-
date products that may become necessary during the next
years. For the sub-fraction of potential candidate products
that contain CFS identified by environmental hazard
criteria, the figure is roughly 25% smaller.It must be noted that our analysis of uses was based
on the exact wording of the use descriptions in the
German PPP register. Hence, we did not explore the
potential for substituting a candidate product that is
only used for a specific pest and/or crop by an alter-
native product that is authorised for broad-spectrum use
against a large group of pests and/or in multiple crops.
This could further increase the number of compara-
tive product assessments.
In addition to the number of uses, the number of
available alternative products must be taken into account.
The broader the spectrum, the higher will be the workload
for comparatively assessing all products that are available
for a given use. As a further workload indicator, we there-
fore derived the product of all three factors: The number
of potential candidate products × the average number of
uses for which alternatives are potentially available × the
average number of alternative products that is available
for each of these uses. This results in roughly 18,500 cases.
This figure is the number of all possible pairwise
comparisons of candidate products with alternative
products for all common uses of two products. For
the sub-fraction of potential candidate products that con-
tain CFS identified by environmental hazard criteria, the
figure is roughly 20% smaller.
Table 6 Potential availability of alternative products for authorised uses of CFS-containing candidate products in
Germany
Parameter All potential candidate
products (n = 351)
Potential candidate products containing CFS
identified by environmental hazard criteriaa (n = 237)
Availability of alternative products for uses of candidate
products
Number of uses
No alternatives available 1,096 813
Any alternatives available 767 687
1 alternative available 220 162
2 alternatives available 126 112
3 to 5 alternatives available 172 163
6 to 10 alternatives available 82 77
11 to 20 alternatives available 112 118
21 to 50 alternatives available 42 44
51 to 100 alternatives available 12 10
More than 100 alternatives available 1 1
Average spectrum of uses of candidate products Mean number of usesb
Including all uses of candidate products 18 18
Including only uses of candidate products for which
alternatives are available
7 8
Average availability of alternatives Mean number of alternative productsb
For all uses of candidate products 3 4
For all uses of candidate products for which alternatives are
available
7 8
Scenario based on the status of authorised products in May 2013. Candidate products are products containing one or more potential CFS; alternatives are
products containing no potential CFS. aAs defined in the corresponding footnote to Table 4. bArithmetic mean rounded to integer values.
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Estimated case numbers in this paper are based on a
draft CFS list and on a simplistic static scenario, reflect-
ing neither fluctuations in the number of authorised
products nor any potential future trends. Therefore, theTable 7 Potential number of cases for comparative risk assess
Cases defined in terms of…
Productsb Number of all candidate products
Number of candidate products for which alternat
available for one or more of their uses
Uses Number of all authorised uses of candidate prod
Number of authorised uses of candidate product
which alternative products are available
Products × Uses Number of all candidate products times average
of usesc
Number of all candidate products times average
of uses for which alternatives are potentially avai
Products × Uses ×
Alternatives
Number of all possible pairwise risk comparisons
products with alternative products for all commo
Scenario based on the status of authorised products in May 2013. aAs defined in th
containing one or more potential CFS; alternatives are products containing no pote
dCalculated by multiplying the number of all candidate products with the average n
number of such alternatives for every use; non-rounded mean values were used forfigures should not be taken as precise estimates but ra-
ther as indications of the expectable dimension of the
upcoming demands on comparative assessments. In any
case, the results of the present study indicate that several








ives are 345 232
ucts 1,863 1,501








e corresponding footnote to Table 4. bCandidate products are products
ntial CFS. cCalculated with non-rounded values for mean numbers of uses.
umber of uses for which alternatives are potentially available and the mean
the calculations.
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PPPs may pose a formidable challenge to competent
authorities. Not only are the quantitative demands con-
siderable, the established assessment methodologies for
PPPs and the existing organisational arrangements are
also only designed for checking compliance of individual
PPPs with legal acceptability criteria. They were not
developed for comparing products with each other.
New data handling systems, assessment procedures,
and decision rules might hence be required for efficiently
dealing with the new task.
The comparative agronomic assessment and the com-
parative safety assessment may be performed either
subsequently or in parallel. The EPPO guidance on com-
parative assessment proposed that the agronomic assess-
ment should be carried out first [14], and the latest draft
of the forthcoming Commission guidance document sug-
gests the same [15]. With the aim of optimal efficiency of
the overall procedure, this appears to be a rational and
self-evident approach, as the agronomic assessment can
be expected to provide a strong filter. Thus, the novel and
demanding task of comparing the human and environ-
mental risks of different products would be limited to the
lowest possible number of cases. On the other hand,
however, it must be taken into consideration that the
agronomic part of the assessment includes criteria
that need further interpretation and specification, in
particular the requirement for no ‘significant’ economic or
practical disadvantages. Corresponding definitions of sig-
nificance may be based on isolated agronomic consi-
derations, but it is also imaginable, that the assessment of
the significance of economic disadvantages should take
account of potential advantages for human health and the
environment. Thus, the number of cases for comparative
human and environmental risk assessments will depend
on the detailed criteria and procedural arrangements of
the overall process.
The workload for performing a complete set of com-
parative human and environmental risk assessments for
all the uses of a candidate product will certainly be quite
different, depending on the respective product. These
different assessment situations result from the different
numbers of uses of potential candidate products, which
vary between one and a few hundreds, and also from the
different numbers of potentially available alternatives,
which range between zero and more than a hundred
(Tables 5 and 6). In addition, the initial comparative
assessments of substances available for a certain common
use may be more demanding than a repeated assessment
that is triggered by an application for authorisation of
another product for the same use. Furthermore, the
risks resulting from different uses of the same prod-
uct may be quite similar or even identical, and most
likely there will also be situations where the availablespectrum of candidate products and alternative products
is identical for different uses. Thus, a more detailed assess-
ment of the workload from comparative risks assessments
and the development of an optimal strategy for efficiently
dealing with the issue would need to consider these
different types of assessment situations. Such analyses
will become possible as soon as the final official CFS
list becomes available.
Besides the need to further clarify these details, the
high number of expectable cases calls for the develop-
ment of an electronic decision support instrument which
would enable competent authorities to rapidly carry out
initial comparative risk assessments. Such a tool should
allow to filter out clear-cut cases in a semi-automatic
manner and to separate them from borderline cases which
require in-depth expert judgment. To this end, the legal
requirement for a significant risk reduction needs to be
translated into well-defined programmable decision rules.
In addition, an efficient application of such a computer-
based decision support tool depends on the availability of
a continuously updated database with all regulatory rele-
vant information on the risks of individual products that
is required for the comparative assessments. In Germany,
regulatory risk assessment reports for individual PPPs cur-
rently exist in the form of text files only, and the same
may presumably apply to most other EU Member States.
For performing a comparative assessment, all the relevant
risk indicators, such as TER values for the various
ecotoxicological endpoints, must therefore be compiled
manually from the individual assessment reports. Improv-
ing this situation is essential for a less time-consuming
future practice. In addition, efforts should be made to
identify representative endpoints or to define suitable indi-
cators for facilitating decision-making within the process,
e.g. for sorting products according to their risk. Within a
broader scope, cooperation between Member States
authorities may be considered as a further means for
efficiently dealing with the large numbers of compara-
tive risk assessments needed. Comparative risk assess-
ment of PPPs is clearly a national task, but a zonal
authorisation of PPPs across different Member States
has been introduced with the new PPP Regulation. In
this situation, sharing the workload for comparative
risk assessments between Member States in the same zone
seems to be a self-suggesting option that deserves further
exploration.
Conclusions
The expectable number of cases for comparative assess-
ments of PPPs is high. In Germany, it may comprise up
to a quarter of all products and half of all uses of products.
This puts regulatory authorities under considerable pres-
sure to develop appropriate strategies for efficient hand-
ling of the task.
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Data presented in this study were generated by systemat-
ically compiling and interlinking information from three
different sources:
– The FCEC report to the European Commission
[11] for information on CFS properties of
approved active substances (approval status as
of 31 January 2013)
– The EU Pesticides database [19] for allocating
approved active substances to use categories
– The database on Authorised Plant Protection
Products of the German Federal Office of
Consumer Protection and Food Safety (BVL) [20]
for information on the number, nature, active
ingredients, uses, and use categories of authorised
PPP in Germany (authorisation status as of
May 2013)
A list of potential CFS was derived from the FCEC
report by aggregating relevant information as follows:
– CFS criterion 1 (low ADI/ARfD/AOEL): Separate
assessments of ADI, ARfD, and AOEL values
(Tables A1, A2, and A3 of the FCEC report) were
merged under the assumption that the following
decision rule applies: values are considered to
fulfil the criterion when they are below the 5%
percentile of a use group as defined in the EU
pesticides database.
– CFS criterion 2 (two PBT criteria): Separate
assessments of half-life in water, sediments,
and soil (Tables A5, A7, and A9 of the FCEC report)
were merged for assessments of persistence (P).
Assessments of bioaccumulation (B) were directly
retrieved (from Table A10 of the FCEC report).
Assessments of aquatic toxicity (TAQUA) were
generated by merging separate assessments of the
toxicity to fish, algae, daphnids, and other aquatic
species (as provided in Tables A11, A12, A13,
and A14 of the FCEC report). Assessments of
human toxicity (THUMAN) were obtained by
merging the separate information on CMR
and STOT RE classifications (provided in
Tables A16, A20, A22, A24, A26, and A 27
of the FCEC report).
– CFS criterion 4 (non-active isomers): Assessments
were directly abstracted (from Table A15 of the
FCEC report).
– CFS criterion 6 toxic for (reproduction 1A/1B):
Separate information on existing and
forthcoming classifications of reproductive
toxicity was merged (from Tables A22 and A23
of the FCEC report).– CFS criterion 7 (endocrine disrupting properties):
For assessments of endocrine disrupting properties
according to the interim criteria laid down in
Regulation (EC) No 1272/2008, i.e. substances
that are classified as both carcinogenic
category 2 and toxic for reproduction category 2,
separate information on these two properties
(in Tables A21 and A25 of the FCEC report)
were combined accordingly.
– CFS criteria 3 and 5 (‘nature of critical effects’
and carcinogen 1A/1B): No substances fulfilling
any of these criteria were identified in the
FCEC report.
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